Partner Content Partner Content 4 Reasons Why Asia is the Next Hub of Microbiome Innovation Microbiome R&D in Asia-Pacific
Partner Content Partner Content 2 weeks until SMi’s Pharma Microbiology West Coast Conferenc... 2 weeks until SMi’s Pharma Microbiology West Coast
Partner Content Partner Content Clinical Development & Manufacturing Challenges for Microbio... Unresolved Challenges in Microbiome Drug Development
News Drugs could mimic gut bacteria benefits to treat diabetes It may be possible to design drugs that mimic the positive health benefits of gut bacteria to treat diseases such as type II diabetes, a new study has found.
Partner Content Partner Content Review Microbiome Start-Up Success Stories & Business Models Your Invite - Microbiome Start-Up Focus Evening
Partner Content Partner Content Regulatory Guidance for Microbiome-Based Therapeutics Join The Microbiome Movement
News Neurogene drops high-dose arm in Rett study after death The patient affected by a serious adverse event in Neurogene's clinical trial of Rett syndrome gene therapy has now died
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
